Vestmark Advisory Solutions Inc. boosted its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS – Free Report) by 26.9% in the 3rd quarter, HoldingsChannel.com reports. The institutional investor owned 9,484 shares of the semiconductor company’s stock after buying an additional 2,011 shares during the quarter. Vestmark Advisory Solutions Inc.’s holdings in Synopsys were worth $4,679,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Alliance Wealth Advisors LLC UT purchased a new position in shares of Synopsys during the 3rd quarter worth $1,262,000. AMJ Financial Wealth Management purchased a new stake in shares of Synopsys in the 3rd quarter worth $539,000. Lansforsakringar Fondforvaltning AB publ raised its holdings in Synopsys by 24.3% in the 3rd quarter. Lansforsakringar Fondforvaltning AB publ now owns 58,588 shares of the semiconductor company’s stock worth $28,907,000 after purchasing an additional 11,454 shares during the period. Princeton Capital Management LLC lifted its position in Synopsys by 8.4% during the third quarter. Princeton Capital Management LLC now owns 1,060 shares of the semiconductor company’s stock valued at $523,000 after purchasing an additional 82 shares in the last quarter. Finally, Rossby Financial LCC lifted its position in Synopsys by 7.2% during the third quarter. Rossby Financial LCC now owns 820 shares of the semiconductor company’s stock valued at $401,000 after purchasing an additional 55 shares in the last quarter. 85.47% of the stock is owned by hedge funds and other institutional investors.
Insider Activity
In related news, insider Janet Lee sold 250 shares of the business’s stock in a transaction dated Monday, January 12th. The stock was sold at an average price of $530.00, for a total value of $132,500.00. Following the sale, the insider directly owned 11,959 shares in the company, valued at approximately $6,338,270. The trade was a 2.05% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the firm’s stock in a transaction that occurred on Friday, December 19th. The shares were sold at an average price of $460.77, for a total value of $1,685,035.89. Following the transaction, the chief financial officer owned 17,842 shares of the company’s stock, valued at $8,221,058.34. This represents a 17.01% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 4,157 shares of company stock valued at $1,945,036 in the last three months. Insiders own 0.62% of the company’s stock.
Synopsys Trading Down 4.3%
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, December 10th. The semiconductor company reported $2.90 earnings per share for the quarter, topping analysts’ consensus estimates of $2.79 by $0.11. The firm had revenue of $2.25 billion during the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a net margin of 18.89% and a return on equity of 7.89%. Synopsys’s revenue for the quarter was up 37.8% on a year-over-year basis. During the same quarter in the prior year, the business earned $3.40 earnings per share. Synopsys has set its FY 2026 guidance at 14.320-14.400 EPS and its Q1 2026 guidance at 3.520-3.580 EPS. On average, equities analysts expect that Synopsys, Inc. will post 10.64 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of analysts have commented on SNPS shares. Morgan Stanley upped their price target on Synopsys from $510.00 to $550.00 and gave the stock an “overweight” rating in a research report on Friday, December 12th. Rosenblatt Securities reiterated a “buy” rating and set a $560.00 price objective on shares of Synopsys in a research note on Friday. Wall Street Zen raised shares of Synopsys from a “sell” rating to a “hold” rating in a report on Saturday, December 13th. Wells Fargo & Company lifted their price target on shares of Synopsys from $445.00 to $500.00 and gave the company an “equal weight” rating in a report on Thursday, December 11th. Finally, Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and dropped their price target for the stock from $525.00 to $500.00 in a research report on Monday, December 8th. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has given a Sell rating to the company’s stock. According to data from MarketBeat, Synopsys has a consensus rating of “Hold” and a consensus price target of $547.00.
View Our Latest Stock Report on Synopsys
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
See Also
- Five stocks we like better than Synopsys
- Elon Musk already made me a “wealthy man”
- Elon’s Secret AI Partner?
- Silver $500? The “Deficit Math” says it’s possible.
- Unlocked: Elon Musk’s Next Big IPO
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
